Citation: | LU Baode, WEI Liuxing, LI Zhenjie, LIN Zhidi, HUANG Yongping. Effects and mechanism of long non-coding RNA LINC02178 on proliferation, invasion and migration of bladder cancer cells[J]. Journal of Clinical Medicine in Practice, 2023, 27(10): 36-41. DOI: 10.7619/jcmp.20223660 |
To investigate the expression of long non-coding RNA LINC02178 in bladder cancer and its effects on the proliferation, invasion and migration of bladder cancer cells.
The expression level of LINC02178 in bladder cancer tissues was analyzed based on the public database. The expression of LINC02178 in bladder cancer cells was detected by quantitative reverse transcription polymerase chain reaction (RT-qPCR). Si-LINC02178 and si-NC fragments were transfected into J82 cells, and the changes of proliferation, invasion and migration of the expression of LINC02178 after silencing were detected by Methyl Thiazolyl Tetrazolium (MTT) and Transwell methods. The protein expression levels of phosphatidylinositol-3-kinase (PI3K), phosphorylated PI3K(p-PI3K), protein kinase B(Akt), phosphorylated Akt(p-Akt) protein were detected by Western blot.
LINC02178 was highly expressed in bladder cancer tissues, and the survival prognosis of patients with high expression was worse compared with those with low expression (P < 0.05). The expression of LINC02178 in bladder cancer cell lines J82, T24 and 5637 was significantly higher than that in normal bladder epithelial cells (P < 0.05). The cell proliferation ability of the si-LINC02178 group was lower than that of the si-NC group (P < 0.05). The number of cells invaded in the si-LINC02178 group and si-NC group was (91.33±2.02) and (179.30±4.26), and the number of cells migrated was (98.33±3.84) and (196.30±2.73), respectively, which showed statistically significant difference between the two groups (P < 0.05). After silencing LINC02178, the expression of p-PI3K and p-Akt protein in cells was down-regulated, while PI3K and Akt had no significant changes (P>0.05).
LINC02178 expression is associated with poor prognosis of patients with bladder cancer. Silencing LINC02178 expression can inhibit the proliferation, invasion and migration of bladder cancer cells, which may be regulated by the PI3K/Akt signaling pathway.
[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
|
[2] |
KOPP F, MENDELL J T. Functional classification and experimental dissection of long noncoding RNAs[J]. Cell, 2018, 172(3): 393-407. doi: 10.1016/j.cell.2018.01.011
|
[3] |
SUN Z L, JING C Y, XIAO C T, et al. An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients[J]. Aging, 2020, 12(15): 15624-15637. doi: 10.18632/aging.103718
|
[4] |
WITJES J A, BRUINS H M, CATHOMAS R, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines[J]. Eur Urol, 2021, 79(1): 82-104. doi: 10.1016/j.eururo.2020.03.055
|
[5] |
PATEL V G, OH W K, GALSKY M D. Treatment of muscle-invasive and advanced bladder cancer in 2020[J]. CA Cancer J Clin, 2020, 70(5): 404-423. doi: 10.3322/caac.21631
|
[6] |
KIM I H, LEE H J. Perioperative systemic treatment for muscle-invasive bladder cancer: current evidence and future perspectives[J]. Int J Mol Sci, 2021, 22(13): 7201. doi: 10.3390/ijms22137201
|
[7] |
SUNG H, SIEGEL R L, TORRE L A, et al. Global patterns in excess body weight and the associated cancer burden[J]. CA Cancer J Clin, 2019, 69(2): 88-112. doi: 10.3322/caac.21499
|
[8] |
ZHANG X Y, XIE K, ZHOU H H, et al. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance[J]. Mol Cancer, 2020, 19(1): 47. doi: 10.1186/s12943-020-01171-z
|
[9] |
XIE Y, DANG W, ZHANG S W, et al. The role of exosomal noncoding RNAs in cancer[J]. Mol Cancer, 2019, 18(1): 37. doi: 10.1186/s12943-019-0984-4
|
[10] |
MAO Q X, LV M H, LI L F, et al. Long intergenic noncoding RNA 00641 inhibits breast cancer cell proliferation, migration, and invasion by sponging miR-194-5p[J]. J Cell Physiol, 2020, 235(3): 2668-2675. doi: 10.1002/jcp.29170
|
[11] |
CHEN C, WANG X, LIU T Z, et al. Overexpression of long non-coding RNA RP11-363E7.4 inhibits proliferation and invasion in gastric cancer[J]. Cell Biochem Funct, 2020, 38(7): 921-931. doi: 10.1002/cbf.3514
|
[12] |
IACCARINO I, KLAPPER W. LncRNA as cancer biomarkers[J]. Methods Mol Biol, 2021, 2348: 27-41.
|
[13] |
吴昊明, 傅广波. 长链非编码RNA SChLAP1表达水平在前列腺癌组织中的临床意义及预后关系[J]. 实用临床医药杂志, 2022, 26(5): 30-33, 38. doi: 10.7619/jcmp.20214427
|
[14] |
WANG Y, LI X, CHEN W, et al. The common region of lncRNAs UCA1 and UCA1α contributes to the bladder cancer tumorigenesis[J]. Eur J Cancer Prev, 2021, 30(5): 389-392. doi: 10.1097/CEJ.0000000000000642
|
[15] |
QUAN J, PAN X, ZHAO L W, et al. LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis[J]. Onco Targets Ther, 2018, 11: 6415-6424. doi: 10.2147/OTT.S167853
|
[16] |
DING Z S, YING W W, HE Y H, et al. lncRNA-UCA1 in the diagnosis of bladder cancer: a meta-analysis[J]. Medicine, 2021, 100(11): e24805. doi: 10.1097/MD.0000000000024805
|
[17] |
ALIPOOR B, PARVAR S N, SABATI Z, et al. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance[J]. Mol Biol Rep, 2020, 47(8): 6357-6374. doi: 10.1007/s11033-020-05695-x
|
[18] |
GHAFOURI-FARD S, ESMAEILI M, TAHERI M. H19 lncRNA: roles in tumorigenesis[J]. Biomed Pharmacother, 2020, 123: 109774. doi: 10.1016/j.biopha.2019.109774
|
[19] |
PAN J F, HUANG Z D, LIN H C, et al. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma[J]. BMC Cancer, 2022, 22(1): 1132. doi: 10.1186/s12885-022-10232-z
|
[20] |
CHEN Y, WANG D, SHU T, et al. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway[J]. Bioengineered, 2021, 12(2): 11410-11422. doi: 10.1080/21655979.2021.2008738
|